Efforts by physicians to ensure patient access to the most appropriate treatment can often be at odds with the financial interests of payers and their stakeholders, through a process known as prior authorization. In a survey by the American Medical Association, more than 50 percent of physicians reported experiencing a 20 percent rejection rate from insurers on first-time prior authorization requests for pharmaceutical treatments, while more than one-third reported experiencing a 20 percent rejection rate on first-time prior authorization requests for diagnostics and procedures. Read more here.
Last Updated on May 13, 2020 by Aimed Alliance
